These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Diffusion-weighted echo-planar MRI of the brain with calculated ADCs: a useful tool in the differential diagnosis of tumor necrosis from abscess? Dorenbeck U, Butz B, Schlaier J, Bretschneider T, Schuierer G, Feuerbach S. J Neuroimaging; 2003 Oct; 13(4):330-8. PubMed ID: 14569825 [Abstract] [Full Text] [Related]
24. The differences of water diffusion between brain tissue infiltrated by tumor and peritumoral vasogenic edema. Pavlisa G, Rados M, Pavlisa G, Pavic L, Potocki K, Mayer D. Clin Imaging; 2009 Oct; 33(2):96-101. PubMed ID: 19237051 [Abstract] [Full Text] [Related]
26. Spectroscopic, diffusion and perfusion magnetic resonance imaging at 3.0 Tesla in the delineation of glioblastomas: preliminary results. Di Costanzo A, Trojsi F, Giannatempo GM, Vuolo L, Popolizio T, Catapano D, Bonavita S, d'Angelo VA, Tedeschi G, Scarabino T. J Exp Clin Cancer Res; 2006 Sep; 25(3):383-90. PubMed ID: 17167979 [Abstract] [Full Text] [Related]
27. Diffusion-weighted MRI for nodal staging of head and neck squamous cell carcinoma: impact on radiotherapy planning. Dirix P, Vandecaveye V, De Keyzer F, Op de Beeck K, Poorten VV, Delaere P, Verbeken E, Hermans R, Nuyts S. Int J Radiat Oncol Biol Phys; 2010 Mar 01; 76(3):761-6. PubMed ID: 19540069 [Abstract] [Full Text] [Related]
29. Pilomyxoid astrocytoma: diagnosis, prognosis, and management. Komotar RJ, Mocco J, Jones JE, Zacharia BE, Tihan T, Feldstein NA, Anderson RC. Neurosurg Focus; 2005 Jun 15; 18(6A):E7. PubMed ID: 16048293 [Abstract] [Full Text] [Related]
30. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors]. Lichy MP, Bachert P, Hamprecht F, Weber MA, Debus J, Schulz-Ertner D, Schlemmer HP, Kauczor HU. Rofo; 2006 Jun 15; 178(6):627-33. PubMed ID: 16703499 [Abstract] [Full Text] [Related]
31. Posttreatment imaging in head and neck cancer. Hermans R. Eur J Radiol; 2008 Jun 15; 66(3):501-11. PubMed ID: 18328660 [Abstract] [Full Text] [Related]
32. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI. Pirzkall A, Li X, Oh J, Chang S, Berger MS, Larson DA, Verhey LJ, Dillon WP, Nelson SJ. Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):126-37. PubMed ID: 15093908 [Abstract] [Full Text] [Related]
33. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas. Law M, Oh S, Johnson G, Babb JS, Zagzag D, Golfinos J, Kelly PJ. Neurosurgery; 2006 Jun 01; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889 [Abstract] [Full Text] [Related]
34. Functional MRI for the prediction of treatment response in head and neck squamous cell carcinoma: potential and limitations. King AD, Thoeny HC. Cancer Imaging; 2016 Aug 19; 16(1):23. PubMed ID: 27542718 [Abstract] [Full Text] [Related]
37. Carotid sinus syncope in head and neck cancer. Bauer CA, Redleaf MI, Gartlan MG, Tsue TT, McColloch TM. Laryngoscope; 1994 Apr 19; 104(4):497-503. PubMed ID: 8164493 [No Abstract] [Full Text] [Related]
38. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy. Miller FR, Karnad AB, Eng T, Hussey DH, Stan McGuff H, Otto RA. Head Neck; 2008 Jan 19; 30(1):28-34. PubMed ID: 17657782 [Abstract] [Full Text] [Related]
39. [Value of technetium-99m in cerebral scintigraphy]. Oberson R, Martini T. Ann Radiol (Paris); 1967 Jan 19; 10(7):487-99. PubMed ID: 4305641 [No Abstract] [Full Text] [Related]